{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:37:41Z","timestamp":1791261461741,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473853"],"award-info":[{"award-number":["82473853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361148716"],"award-info":[{"award-number":["82361148716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030059"],"award-info":[{"award-number":["32030059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biomaterials.2025.123630","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:53:50Z","timestamp":1755100430000},"page":"123630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"325","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-2725","authenticated-orcid":false,"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6487","key":"10.1016\/j.biomaterials.2025.123630_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123630_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10555-021-10004-4","article-title":"Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets","volume":"40","author":"Andersen","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123630_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123630_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers9110157","article-title":"Pancreatic cancer chemoresistance to gemcitabine","volume":"9","author":"Amrutkar","year":"2017","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123630_bib5","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123630_bib6","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.3748\/wjg.v20.i26.8482","article-title":"hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review","volume":"20","author":"Nordh","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123630_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/00365520902745039","article-title":"Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions","volume":"44","author":"Andersson","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123630_bib8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","article-title":"Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress","volume":"164","author":"Jiang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2025.123630_bib9","article-title":"Targeting pyrimidine metabolism in the era of precision cancer medicine","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123630_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chembiol.2018.03.005","article-title":"Dependence on the pyrimidine biosynthetic enzyme DHODH is a synthetic lethal vulnerability in mutant KRAS-driven cancers","volume":"25","author":"Koundinya","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123630_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10637-018-0598-5","article-title":"Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis","volume":"36","author":"Kang","year":"2018","journal-title":"Invest. N. Drugs"},{"issue":"397","key":"10.1016\/j.biomaterials.2025.123630_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0026","article-title":"Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism","volume":"9","author":"Karagiannis","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123630_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123630_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114357","article-title":"Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment","volume":"187","author":"Tarannum","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123630_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-020-00740-5","article-title":"Challenges in nanomedicine clinical translation","volume":"10","author":"Metselaar","year":"2020","journal-title":"Drug Deliv Transl Res"},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123630_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007356","article-title":"Polyphenol-containing nanoparticles: synthesis, properties, and therapeutic delivery","volume":"33","author":"Guo","year":"2021","journal-title":"Adv. Mater."},{"issue":"48","key":"10.1016\/j.biomaterials.2025.123630_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201702714","article-title":"A metal-polyphenol network coated nanotheranostic system for metastatic tumor treatments","volume":"13","author":"Fan","year":"2017","journal-title":"Small"},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123630_bib18","article-title":"Penetrating micelle for reversing immunosuppression and drug resistance in pancreatic cancer treatment","volume":"18","author":"Chen","year":"2022","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123630_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/acs.molpharmaceut.6b01027","article-title":"Lipid\u2013drug conjugate for enhancing drug delivery","volume":"14","author":"Irby","year":"2017","journal-title":"Mol. Pharm."},{"issue":"7824","key":"10.1016\/j.biomaterials.2025.123630_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41586-020-2475-6","article-title":"Mitochondrial ubiquinol oxidation is necessary for tumour growth","volume":"585","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nature"},{"issue":"87","key":"10.1016\/j.biomaterials.2025.123630_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq2424","article-title":"Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8(+) T cell metabolic fitness and function in tumors","volume":"8","author":"Yang","year":"2023","journal-title":"Sci Immunol"},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123630_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311500","article-title":"Mitocytosis mediated by an enzyme-activable mitochondrion-disturbing polymer-drug conjugate enhances active penetration in glioblastoma therapy","volume":"36","author":"Xiang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123630_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jconrel.2022.07.018","article-title":"Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment","volume":"349","author":"Hailing","year":"2022","journal-title":"J. Contr. Release"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123630_bib24","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/1078-0432.CCR-22-2576","article-title":"hENT1 expression predicts response to gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma","volume":"28","author":"Perera","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2025.123630_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2019.11.010","article-title":"Encapsulated microRNA by gemcitabine prodrug for cancer treatment","volume":"316","author":"Zhang","year":"2019","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123630_bib26","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s43018-022-00470-2","article-title":"Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer","volume":"3","author":"Cappellesso","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123630_bib27","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1038\/srep04410","article-title":"Targeting pancreatic ductal adenocarcinoma acidic microenvironment","volume":"4","author":"Cruz-Monserrate","year":"2014","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123630_bib28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","article-title":"Lipophilicity and its relationship with passive drug permeation","volume":"28","author":"Liu","year":"2011","journal-title":"Pharm. Res."},{"issue":"51","key":"10.1016\/j.biomaterials.2025.123630_bib29","doi-asserted-by":"crossref","first-page":"34996","DOI":"10.1021\/acsnano.4c13425","article-title":"Metabolic nanoregulators induce ferroptosis and change metabolite flow to reverse immunosuppressive tumor microenvironment","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"issue":"1765","key":"10.1016\/j.biomaterials.2025.123630_bib30","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0153","article-title":"The pervasiveness of macropinocytosis in oncological malignancies","volume":"374","author":"Commisso","year":"2019","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"Suppl 5","key":"10.1016\/j.biomaterials.2025.123630_bib31","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123630_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2018.01.107","article-title":"Leflunomide: a promising drug with good antitumor potential","volume":"496","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123630_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2019.151058","article-title":"Mitochondria regulation in ferroptosis","volume":"99","author":"Wang","year":"2020","journal-title":"Eur. J. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123630_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cyto.a.20712","article-title":"Cell type specific applicability of 5-ethynyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry","volume":"75","author":"Diermeier-Daucher","year":"2009","journal-title":"Cytometry A"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123630_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccr.2012.08.001","article-title":"EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma","volume":"22","author":"Navas","year":"2012","journal-title":"Cancer Cell"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:04:17Z","timestamp":1779717857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225005496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S0142961225005496"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123630","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123630"}}